Project Grant K23DK146153
- Federal Grant Award Summary New York University School of Medicine received a $842,633 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 24, 2025, with completion targeted for July 31, 2030. The award supports the development of an optimal prehabilitation program for kidney transplant (KT) candidates on hemodialysis. The research...
- Federal Project Grant Award Summary New York University School of Medicine received a $1,721,026 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 10, 2025, with completion scheduled for August 31, 2030. The research initiative will deliver a comprehensive analysis of long-term health outcomes for living kidney donors (LKDs) utilizing the...
- Federal Project Grant Award Summary New York University School of Medicine received a $847,495 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 19, 2026, with completion targeted for November 30, 2030. The award funds research to address critical kidney transplant allocation inefficiencies, specifically examining the acceptability...
- Federal Project Grant Award Summary New York University School of Medicine received a $843,457 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for June 30, 2030. The research addresses critical inefficiencies in the U.S. kidney allocation system by developing and evaluating an Adenosine Triphosphate...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Children's Hospital of Philadelphia Research Institute a $343,278 Project Grant effective July 16, 2025, through March 31, 2030, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This award supports a multi-omic investigation of uremic toxin sources and accumulation in children with kidney failure, addressing the high morbidity and...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant totaling $155,562 to Stony Brook University (operating through The Research Foundation For The State University Of New York) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, dated December 11, 2025, supports research investigating alterations of branched chain amino acid (BCAA) catabolism in acute kidney injury...
- Federal Grant Award Summary New York University School of Medicine received a $847,371 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with completion expected by July 31, 2030. The grant supports research on individualized immunosuppression in kidney transplant recipients using real-world evidence and artificial intelligence...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Trustees of Columbia University in the City of New York a Project Grant of $231,270 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with completion targeted for August 31, 2027. This award supports large-scale exome-wide rare variant association studies designed to advance chronic kidney disease (CKD) risk...
- Federal Grant Award Summary The University of California, San Diego received a $5.67 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a four-year research initiative examining renal metabolism in acute kidney injury (AKI) associated with sepsis. Awarded September 15, 2025, with completion scheduled for September 14, 2029, this research...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
New York University School of Medicine received a $206,496 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective May 1, 2026, with a completion date of January 31, 2031. The award funds the Surveillance of Nutritional Risk for Acute Kidney Injury in Critically Ill Kids (SNACK) study, which aims to evaluate whether poor baseline nutritional status is a modifiable risk factor for acute kidney injury (AKI) in pediatric intensive care unit (PICU) patients. The research will characterize nutritional status through comprehensive assessments beyond standard anthropometrics, including dietary questionnaires, malnutrition screening tools, mid-upper arm circumference measurements, skin fold thickness, hand grip strength assessments, and muscle ultrasound examinations in a cohort of 200 high-risk PICU patients. The study will identify novel blood-based nutritional biomarkers and evaluate associations between nutritional factors and AKI development or progression using objective clinical measures such as serum creatinine and urine output. The deliverables include detailed nutritional risk subphenotyping and biomarker characterization that may identify targetable interventions to improve outcomes in critically ill children with AKI.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $206.5k | 4/24/26 |